Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma

Slides:



Advertisements
Similar presentations
A System for Long-term Urodynamic Studies Without Catheters
Advertisements

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis  Maria I. Carlo, Darren R.
Volume 70, Issue 1, Pages (July 2016)
Global Trends in Testicular Cancer Incidence and Mortality
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Validity and Reliability of a Questionnaire for Evaluating Nocturia, Nocturnal Enuresis and Sleep-Interruptions in an Elderly Population  M.H. Bing, L.A.
Volume 51, Issue 1, Pages (January 2007)
Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey  Varant Kupelian,
Volume 50, Issue 5, Pages (November 2006)
Lack of KRAS and BRAF Mutation in Renal Cell Carcinoma
Volume 69, Issue 1, Pages (January 2016)
Volume 71, Issue 4, Pages (April 2017)
Histologic Grading of Noninvasive Papillary Urothelial Neoplasms
Let the Games Begin (with EAU Approval)
Volume 68, Issue 1, Pages (July 2015)
Volume 51, Issue 5, Pages (May 2007)
Prostate Cancer Epidemic in Sight?
Volume 45, Issue 4, Pages (April 2004)
Volume 74, Issue 1, Pages (July 2018)
Volume 50, Issue 5, Pages (November 2006)
Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications  Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi,
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 54, Issue 4, Pages (October 2008)
Volume 52, Issue 5, Pages (November 2007)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Volume 70, Issue 3, Pages (September 2016)
Prostate Cancer Detection: A View of the Future
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Volume 66, Issue 5, Pages (November 2014)
Volume 68, Issue 1, Pages (July 2015)
Volume 70, Issue 1, Pages (July 2016)
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Volume 63, Issue 4, Pages (April 2013)
Prostate Cancer Epidemic in Sight?
James N. Armitage, Stuart O. Irving, Neil A. Burgess  European Urology 
Volume 50, Issue 3, Pages (September 2006)
Volume 61, Issue 6, Pages (June 2012)
Volume 74, Issue 3, Pages (September 2018)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 66, Issue 6, Pages (December 2014)
Volume 51, Issue 5, Pages (May 2007)
Trends in Hypospadias Surgery: Results of a Worldwide Survey
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 59, Issue 1, Pages (January 2011)
Volume 70, Issue 3, Pages e72-e74 (September 2016)
Volume 52, Issue 1, Pages (July 2007)
The Economic Costs of Overactive Bladder in Germany
Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl  European Urology 
Is Simple Enucleation a Minimal Partial Nephrectomy Responding to the EAU Guidelines’ Recommendations?  Vincenzo Ficarra, Antonio Galfano, Stefano Cavalleri 
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Testicular Cancer Variations in Time and Space in Europe
Sergio Bracarda  European Urology Supplements 
European Urology is “Your” Journal
Epidemiology of Renal Cell Carcinoma
The Start-Up of the Platinum Journal: A Fascinating Challenge
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Economic Burden of Bladder Cancer Across the European Union
Volume 53, Issue 2, Pages (February 2008)
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Annika Berntsen, Poul F. Geertsen, Inge Marie Svane  European Urology 
Organization news Archives of Physical Medicine and Rehabilitation
Joaquim Bellmunt  European Urology Supplements 
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Jan Roigas  European Urology Supplements 
Volume 51, Issue 5, Pages (May 2007)
In This Issue Cell Volume 145, Issue 3, (April 2011)
Presentation transcript:

Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma Michal Sarfaty, Moshe Leshno, Noa Gordon, Assaf Moore, Victoria Neiman, Eli Rosenbaum, Daniel A. Goldstein  European Urology  Volume 73, Issue 4, Pages 628-634 (April 2018) DOI: 10.1016/j.eururo.2017.07.041 Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 1 Markov model. European Urology 2018 73, 628-634DOI: (10.1016/j.eururo.2017.07.041) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 2 Univariable sensitivity analyses. ICER=incremental cost-effectiveness ratio; QALY=quality-adjusted life-year. European Urology 2018 73, 628-634DOI: (10.1016/j.eururo.2017.07.041) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 3 Probability sensitivity analyses. QALY=quality-adjusted life-year. European Urology 2018 73, 628-634DOI: (10.1016/j.eururo.2017.07.041) Copyright © 2017 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.